Methotrexate improves the anti-arthritic effects of Paeoniflorin-6'-O-benzene sulfonate by enhancing its pharmacokinetic properties in adjuvant-induced arthritis rats
Paeoniflorin-6'-O-benzene sulfonate (CP-25), is a novel derivative of paeoniflorin (Pae) with improved anti-arthritic effects. The aim of this study was to evaluate the therapeutic effects and pharmacokinetics of CP-25 when co-administered with MTX in adjuvant-induced arthritis (AA) rats. AA ra...
Main Authors: | James Asenso, Jun Yu, Feng Xiao, Mingyi Zhao, Jian Wang, Yijin Wu, Chun Wang, Wei Wei |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-04-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332218375498 |
Similar Items
-
CP-25 ameliorates methotrexate induced nephrotoxicity via improving renal apoptosis and methotrexate excretion
by: Xiao Wei, et al.
Published: (2021-05-01) -
Regulation of CP-25 on P-glycoprotein in synoviocytes of rats with adjuvant arthritis
by: Hao Tang, et al.
Published: (2019-11-01) -
A review on the pharmacokinetics of paeoniflorin and its anti-inflammatory and immunomodulatory effects
by: Yan-Xi Zhou, et al.
Published: (2020-10-01) -
Gut Microbiota-Based Pharmacokinetics and the Antidepressant Mechanism of Paeoniflorin
by: Jin-Bo Yu, et al.
Published: (2019-03-01) -
A Modified Compound From Paeoniflorin, CP-25, Suppressed Immune Responses and Synovium Inflammation in Collagen-Induced Arthritis Mice
by: Jingyu Chen, et al.
Published: (2018-06-01)